NervGen Pharma Corp. (NGEN) — Defensive Interval Ratio
NervGen Pharma Corp. (NGEN) has a Defensive Interval Ratio of 1 days as of June 2026. Defensive assets of $200.56K (cash $-, short-term investments $0.00, receivables $200.56K) cover 1 days of daily cash needs of $200.09K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
NervGen Pharma Corp. Defensive Interval Ratio (2018–2025)
This chart shows how NervGen Pharma Corp.'s Defensive Interval Ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 1 days, meaning defensive assets of $200.56K can fund 1 days of operations without new revenue. For the complete balance sheet picture, see NervGen Pharma Corp. asset portfolio.
Annual Defensive Interval Ratio for NervGen Pharma Corp. (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for NervGen Pharma Corp. from 2018 to 2025, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See NervGen Pharma Corp. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2 days | $89.19K | $54.06K/day | $- | $8.37K | ▼ -9 days |
| 2024 | 11 days | $512.19K | $46.27K/day | $- | $97.17K | ▲ +5 days |
| 2023 | 6 days | $250.23K | $41.48K/day | $- | $0.00 | ▲ +5 days |
| 2022 | 1 days | $26.79K | $27.75K/day | $- | $- | ▼ -21 days |
| 2021 | 22 days | $64.49K | $2.98K/day | $- | $- | ▼ -9 days |
| 2020 | 30 days | $62.73K | $2.07K/day | $- | $- | ▼ -18 days |
| 2019 | 48 days | $125.84K | $2.60K/day | $- | $- | ▲ +27 days |
| 2018 | 21 days | $25.76K | $1.23K/day | $- | $- | — |